Charles River Laboratories | Fremdkapital



Loan Capital Veränderung Datum
Agilent USD 3.35B 2M 2025-01
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 1.2B 338K 2024-12
Bruker USD 2.06B 202.7M 2024-12
Cardinal Health USD 7.06B 2.84B 2024-12
Charles River Laboratories USD 2.24B 86.45M 2024-12
Cigna USD 28.94B 1.29B 2024-12
CVS Health USD 60.53B 703M 2024-12
Danaher USD 15.98B 476M 2025-03
Dentsply International USD 1.59B 209M 2024-12
Elevance Health USD 28.11B 1.11B 2025-03
Galapagos EUR 7.79M 453K 2025-03
Hologic USD 2.49B 19M 2024-12
Humana USD 12.73B 1.59B 2025-03
Illumina USD 1.49B 498M 2024-12
Incyte USD 32.64M 899K 2025-03
IQVIA Holdings USD 12.84B 545M 2024-12
Laboratory Of America USD 5.57B 163.2M 2025-03
Lonza CHF 4.24B 602M 2024-12
McKesson USD 4.42B 1.27B 2024-12
Merck EUR 6.37B 1.51B 2024-12
Mettler Toledo International USD 1.83B 60.4M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Quest Diagnostics USD 5.86B 243M 2025-03
Revvity USD 3.17B 17.91M 2025-03
Thermo Fisher Scientific USD 31.37B 2.31B 2025-03
United Therapeutics USD 0 0 2025-03
UnitedHealth USD 71.29B 1.07B 2025-03
Walgreens Boots Alliance USD 7.5B 1.02B 2025-02
Waters USD 1.63B 199.76M 2024-12
West Pharmaceutical Services USD 202.6M 2.1M 2025-03



Charles River Laboratories Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.